Tilray Inc (NASDAQ:TLRY) stock fell 0.18% (As on January 10, 11:12:58 AM UTC-4, Source: Google Finance) after the company missed the topline estimates for the second quarter of FY 23. Beverage-alcohol sales increased 56% to $21.4 million, over the prior year quarter, including revenue from acquisitions. Gross profit rose to $40.1 million, a 22% increase, year over year. Adjusted gross margin held at 29% compared to the year ago quarter. Cannabis gross profit increased 37% to $18.6 million from $13.5 million in the prior year quarter, while the gross margin percentage increased to 37% from 23%. This was driven by our success in implementing numerous cost-savings programs, offset in part by our allocated overhead from intentionally reducing production, coupled with the revenue realized from our strategic alliance with HEXO in the current year and in inventory provision in the prior year. Achieved $119.6 million in annualized cash cost-savings since the closing of the Tilray-Aphria transaction in May 2021, up from $108 million as of August 31, 2022. Adjusted EBITDA of $11.7 million, marking the 15^th consecutive quarter of positive adjusted EBITDA. The company is close to achieving the increased annualized cost savings target of $130 million, consistent with the commitment to building a lean, efficient, and dynamic business that will realize tangible and immediate benefits as the market improves. And, in Canada, the company is patient and strategic in building the competitive positioning amid the price compression and difficult operating conditions that the company expect will, inevitably, consolidate the oversupply of licensed producers. These efforts will be supported and enhanced by one of the strongest balance sheets in the industry with close to $433.5 million in cash and marketable securities on-hand.

TLRY in the second quarter of FY 23 has reported the adjusted earnings per share of ($0.06), which is inline with the analysts’ estimates for the adjusted earnings per share of ($0.06). The company had reported the adjusted revenue of $144.1 million in the second quarter of FY 23, missing the analysts’ estimates for revenue of $156.85 million.

Moreover, even as Europe contends with a difficult economic climate that has negatively impacted the cannabis industry, the positive trends towards greater acceptance of medical cannabis and legalization of adult-use continue. In the U.S., Tilray’s businesses include SweetWater Brewing Company, the 10th largest craft brewer in the nation; Breckenridge Distillery; and Manitoba Harvest, a pioneer in hemp, CBD and wellness products; as well as Montauk Brewing Company, the fastest growing craft beer brand and #1 craft brewer in Metro New York, which Tilray Brands acquired in the second quarter of fiscal 2023.